SummaryRMgm-322
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 19662167 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | E.S.C. Bushell; D. Vlachou |
Name Group/Department | Department of Life Sciences |
Name Institute | Imperial College London |
City | London |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-322 |
Principal name | pbmisfit-myc |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Localisation of the myc-tagged MISFIT protein in nuclei of male gametocytes and activated male gametocytes (immunofluorescence assays). A weak, slightly above background signal in female gametocytes, in conjunction with earlier proteomic data, suggests the possibility of low protein expression in females. MISFIT was not detected in asexual blood stage trophozoites or schizonts. |
Fertilization and ookinete | Localisation of the myc-tagged MISFIT protein in nuclei of zygotes and ookinetes. |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Protein (function) Based on phenotype analyses of a mutant lacking expression of MISFIT (RMgm-321)it has been suggested that MISFIT is involved in the regulation of microtubule remodeling during DNA replication and chromosome segregation in mitosis in male gametocytes and/or meiosis in zygotes. |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1038200 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1403800 | ||||||||||||||||||||||||||
Gene product | nuclear formin-like protein MISFIT, putative | male-inherited sporulation factor important for transmission | ||||||||||||||||||||||||||
Gene product: Alternative name | MISFIT, male-inherited sporulation factor important for transmission | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | c-myc | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | The misfit gene was fused to a C-terminal myc tag by replacing 1 kb of the most 3′ terminal portion of the endogenous misfit locus with a double c-myc tagged counterpart. | ||||||||||||||||||||||||||
Commercial source of tag-antibodies | Rabbit anti-myc monoclonal antibody (71D10, New England Biolabs); Rat anti-myc antibody (JAC6, AbCam | ||||||||||||||||||||||||||
Type of plasmid/construct | Plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | ClaI | ||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | The tagging vector carries a C-terminal fragment of pbmisfit, with a unique ClaI restriction site in its centre, cloned in-frame with a double c-myc tag and in tandem with a tgdhfr/ts pyrimethamine-selection cassette. The construct is linearized by cutting with ClaI. Transfection of the linearized construct results in single homologous recombination and replacement of the last 942 bp of the native pbmisfit locus with its myc-tagged version. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |